Tuesday, February 1, 2022

Press Release from NCI: NCI study advances personalized immunotherapy for metastatic breast cancer

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to Press Releases from the National Cancer Institute. New press releases are listed below.

 

 

NCI study advances personalized immunotherapy for metastatic breast cancer
02/01/2022
NCI researchers have shown that an experimental form of immunotherapy that uses an individual's own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer who have exhausted all other treatment options.
This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The Best of Retail: Fashion Adapts to a Tough Reality

BoF is away for its annual break until 2nd January. In the meantime, we invite you to explore highlights of our news and analysis from t...